ANCA相关血管炎眼眶肿物:59例临床、生物学、影像学与组织学表现及治疗转归
糖皮质激素为一线治疗,82%联用免疫抑制剂;环磷酰胺组应答率52%,利妥昔单抗组91%。46%需二线治疗,28%遗留视力损害,17%最终失明。
要点
- 眼眶肿物多为单侧,常源于耳鼻喉受累,组织学以淋巴浆细胞浸润和纤维化为主。
- 利妥昔单抗治疗应答率(91%)高于环磷酰胺(52%),但需注意原文未报告统计学比较。
- 难治性病程与PR3-ANCA阳性、视力丧失及邻近硬脑膜炎相关。
核心结论
- ANCA相关血管炎眼眶肿物与难治性病程及高频后遗症相关,尤其失明。
- 难治性病程与PR3-ANCA阳性、视力丧失及邻近硬脑膜炎相关。
研究设计与样本
- 法国全国回顾性研究,纳入符合ACR标准或Chapel Hill共识定义的ANCA相关血管炎合并眼眶肿物患者59例。
主要发现
- 眼眶肿物单侧47例(80%),多数似源于耳鼻喉受累。
- 32例(54%)有眼眶肿物活检,淋巴浆细胞浸润65%、纤维化55%、肉芽肿48%、血管炎36%。
- 环磷酰胺治疗应答52%,利妥昔单抗治疗应答91%。
关键数值与推荐
- 所有患者除1例外均接受糖皮质激素一线治疗,82%联用免疫抑制剂,主要为环磷酰胺。
临床怎么用
- 对ANCA相关血管炎眼眶肿物患者应警惕难治性病程和高失明风险,需积极评估和治疗。
- PR3-ANCA阳性、视力丧失及邻近硬脑膜炎可能提示难治性病程,应加强监测。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Orbital mass is a rare and sight-threatening manifestation of ANCA-associated vasculitides, which remains a therapeutic challenge. We aimed to describe the presentation, therapeutic management and outcome of ANCA-associated vasculitides-related orbital mass. METHODS: We conducted a French nationwide retrospective study of patients with orbital mass in the setting of ANCA-associated vasculitides according to ACR criteria and/or Chapel Hill Consensus Conference definitions. RESULTS: Fifty-nine patients [33 women, median age 46 (range 7-90) years] were included. Fifty-six (95%) patients had granulomatosis with polyangiitis, two eosinophilic granulomatosis with polyangiitis and one microscopic polyangiitis. Orbital mass was unilateral in 47 (80%) cases, and seemed to develop from ENT involvement in most cases. Orbital mass biopsy was available in 32 (54%) patients, showing lymphoplasmacytic infiltration in 65%, fibrosis in 55%, granulomas in 48% and vasculitis in 36%. All patients but one received glucocorticoids as first-line therapy associated with immunosuppressive agents in 82%, mainly cyclophosphamide. Response to therapy was noted in 52% of patients treated with cyclophosphamide compared with 91% of those treated with rituximab. Twenty-seven (46%) patients required a second-line therapy because of relapse (59%) or refractory course (41%). Sequelae included visual impairment in 28%, with definitive blindness in 17%. Refractory course was associated with PR3-ANCA positivity, visual loss and contiguous pachymeningitis. CONCLUSION: Orbital mass is associated with refractory course and high frequency of sequelae, especially blindness. Refractory course is associated with PR3-ANCA positivity, visual loss and contiguous pachymeningitis.
引用
- Durel CA, Hot A, Trefond L, et al. Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients. Rheumatology (Oxford). 2019. PMID: 30887055. doi:10.1093/rheumatology/kez071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。